肝病藥 的英文怎麼說

中文拼音 [gānbìngyào]
肝病藥 英文
drug for liver disease
  • : 名詞(人和高等動物的消化器官之一) liver
  • : Ⅰ名詞1 (疾病; 失去健康的狀態) illness; sickness; disease; malum; nosema; malady; morbus; vitium...
  • : Ⅰ名詞1 (藥物) medicine; drug; remedy 2 (某些有化學作用的物質) certain chemicals Ⅱ動詞1 [書面...
  • 肝病 : hepatopathy; liver complaint肝病患者 hepatopath; 肝病面容 hepatic face
  1. Differentiation of symptom - complex and medication experience in treating carbuncle of the hypochondrium due to liver ailment

    脅痛的辨證思路與用經驗
  2. 《 international hepatis 》 : regarding to nucleoside analogs with hepatitis b antiviral treatment, the drug - resistance raised genetic barriers they, how do you understand genetic resistance barrier ? do you agree

    《國際》 :關于抗乙毒治療的核苷類似物,物耐性導致基因屏障概念的提出,你如何理解基因耐性屏障?你同意這種說法嗎?
  3. 《 international hepatis 》 : how to avoid resisitance efficently

    國際:怎樣有效的避免耐
  4. 《 international hepatis 》 : what is the main influential factor in drug - resistance variant

    《國際》 : .什麼是耐變異株的主要影響因素?
  5. At present, the traditional chinese medicine which is developed and has a special therapeutic effectiveness includes the cosmetic and healthy food which can resist aging and lots of prescription which can cure gout, hepatic disease, gastrointestinal disease, trachitis, chronic cholecystitis, arthritis, rheumatoid arthritis ( ra ), scapulohumeral periarthritis, gynecopathy, oral ulcer, rhinitis, inflammatory swelling of unknown origin, venereal disease ( vd ), angitis, diabetes, hypertension and so on

    目前開發的具有獨特療效的中有:道家秘傳抗衰老保健美容益壽食品,治療痛風、各種、各種腸胃道、氣管炎、慢性膽囊炎、關節炎、類風濕關節炎、肩周炎、各種婦科、口腔潰瘍、各種鼻炎、無名腫毒、各種性、脈管炎、糖尿、慢性咽炎、高血壓等多種方劑。
  6. Discussion on the relationship between the symptom of chronic liver disease enterogenous endomycin blood and phlegm stagnant heat and study on the effect of quot; ganduqing quot; to them

    慢性腸源性內毒素血癥與痰瘀熱證型關系探討及中毒清對它的影響
  7. This happens in normal pubertal stage, but can also be caused by diseases like testicular or brain tumours, liver diseases, thyroid gland hyperactivity, certain chromosome abnormalities and side - effects of some drugs

    ,也可由睪丸或腦腫瘤、變、甲狀腺亢奮、某些染色體異常、或某些物等引致。
  8. Progress of japanese modern kampo in treating and preventing liver diseases

    日本現代漢方的預防治療進展
  9. The specification is affected toward virus of liver having second already history or the convalescence after second liver virus is affected, had appeared protection antibody has immune power to second liver virus namely, do not need to medication, do not need vaccine of inject second liver, generally speaking, the protection antibody duration that this kind of natural infection forms is long, often be lifetime

    說明既往有乙毒感染史或者乙毒感染后恢復期,已經出現保護性抗體即對乙毒有免疫力,不需要物治療,不需要注射乙疫苗,一般來說,這種自然感染形成的保護性抗體持續時間長,往往是終生的。
  10. In addition to sifuvirtide, fusogen has been developing new drugs for hepatitis b and hepatitis c, using its proprietary platform of computer drug design

    繼西夫韋肽研製成功之後,扶素生物應用自有的計算機物設計平臺,設計出抗乙毒和丙毒的抑制劑。
  11. 《 international hepatis 》 : aasld guideline don ' t suggest lamivudine as naive, but in china lamivudine is the classical drug, what do you think of it

    國際: aasld指南不推薦拉米夫定作為初始核苷類治療物,但是在中國,拉米夫定是經典的抗物,你怎麼認為?
  12. Now the treatment of chronic hepatitis b stress on antiviral treatment, but the nucleoside drugs prone to resistance, what are the consequences once happened resistance

    《國際》 :現在慢乙強調抗毒治療,但核苷類物容易出現耐,一旦出現耐有什麼後果?
  13. Q : now the treatment of chronic hepatitis b stress on antiviral treatment, but the nucleoside drugs prone to resistance, what are the consequences once happened resistance

    《國際》 :現在慢乙強調抗毒治療,但核苷類物容易出現耐,一旦出現耐有什麼後果?
  14. My first question is if hbv nucleoside analogues happened with the resistance there, then the solution is to add - on other nucleoside drugs for combination therapy, or switch another nucleoside drugs

    《國際》 :乙用核苷類似物出現耐后,是加用其他核苷類物,還是轉換另外一種核苷類物?
  15. The person that second liver virus is carried, if liver function 8 or liver result 12 examination is normal word, it is not to need cure at all, also be to be impossible of cure - - those are so called protect liver to protect liver medicine, it is the burden of aggravating liver, 20 to when the value the doctor increases some of income just - - ah

    毒攜帶者,假如功能8項或者功12項的檢查是正常的話,根本是不需要醫治,也是沒有可能醫治的? ?那些所謂的保,一是加重臟的負擔,二十給當值醫生增加些收入而已? ?呵呵。
  16. Q : my first question is if hbv nucleoside analogues happened with the resistance there, then the solution is to add - on other nucleoside drugs for combination therapy, or switch another nucleoside drugs

    《國際》 :乙用核苷類似物出現耐后,是加用其他核苷類物,還是轉換另外一種核苷類物?
  17. Now next step we have to think about the ten years treatment, ten years mutation rate is 10 percent, then 90 % percent can use a drug for 10 years, then you might change the so - called natural cause of diseases

    但是我們要考慮的是10年長期的服,如果10年的變異率是10 % ,仍然在這10年裡面,我們90 %的物療效是用來抑制毒復制,而且效果好,可以延緩俗稱的自然程進展。
  18. The key contents are as follows : the further confirmation and application of the diagnostic cri - teria of the symptom complex of liver disease ; the study of the essence of the symptom complex at the level of or - gan - cell - molecule ; the study of the theory about the emotions of liver disease and drawing up the emotional ques - tionaire ; the research and production of new drugs

    研究的重點內容應包括:證候診斷標準的擴大驗證和推廣應用;從整體?細胞?分子水平研究闡明證本質;情志理論研究並編制證情志量表;新研製。
  19. Chinese medicine empirical prescription ' s effecting on the level of serum elements and the live pathologic condition in sd rats damaged by ccl

    復方中對大鼠血清元素含量及理狀態的影響
  20. Prof ratziu : it is true that we don ' t have a lot of drugs that are very powerful anti - virus of hepatitis b, and i think the choice really now has done to those agents we check the most powerful inhibitors effects on hbv replication, and also who offer the least chances of pre - resistance in the next few years

    我們確實沒有很多強有力的對抗乙毒的物,同時我認為目前我們通過對最強有效的乙毒復制抑制劑的檢驗而把目標鎖定了那些類型的物,而且這些類型的物在未來的幾年內出現基線耐的幾率會很低。
分享友人